论文部分内容阅读
目的:观察应用当先实脾法方治疗原发性肝癌的临床疗效。方法:180例原发性肝癌患者随机分为治疗组(100例)和对照组(80例),治疗组以当先实脾法方治疗,对照组用复方斑蝥胶囊、5-氟尿嘧啶治疗,观察2组治疗前后临床主要症状改善和肿瘤与AFP变化。结果:治疗组总有效率(90%)优于对照组(77.5%),有显著性差异(P<0.05)。治疗组在治疗后临床主要症状改善情况及肿瘤与AFP变化比较,优于对照组治疗后水平,有显著性差异(P<0.05)。结论:当先实脾法方治疗原发性肝癌临床效果满意,且无明显毒副反应。
Objective: To observe the clinical curative effect of the treatment of primary liver cancer with the application of Xianshi spleen prescription. Methods: 180 patients with primary liver cancer were randomly divided into treatment group (100 cases) and control group (80 cases). The treatment group was treated with Xianshi spleen formula, and the control group was treated with compound cantharidin capsule and 5-fluorouracil. Observation 2 The improvement of clinical symptoms and changes of tumor and AFP before and after treatment in the group. Results: The total effective rate (90%) in the treatment group was better than that in the control group (77.5%), with significant difference (P<0.05). The improvement of clinical symptoms and the changes of tumors and AFP after treatment were better in the treatment group than in the control group after treatment, with significant differences (P<0.05). Conclusion: The clinical effect of Xianshi spleen prescription in treating primary liver cancer is satisfactory, and there is no obvious side effect.